Christie Mitri

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Rheumatoid Arthritis Patients

Extracorporeal Membrane Oxygenation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs 83 (1) (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs 83 (1) (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs 83 (1) (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs (2022)
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, François Philippart
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? Drugs (2022)